title: Long-term treatment outcomes of CoreTherm microwave feedback thermotherapy.
abstract: The gold standard for definitive management of symptomatic benign prostatic hypertrophy is transurethral resection of the prostate (TURP). Despite its efficacy, TURP has significant morbidity/mortality concerns such as hemorrhage and transurethral resection syndrome. This is especially worrisome for the medically high-risk patient, but the high rates of retrograde ejaculation found with TURP also pose a problem for young patients. A minimally invasive, outpatient alternative to TURP that has long-term efficacy, low morbidity/mortality, and provides a cost-effective advantage is in high demand. This review article discusses microwave thermotherapy as such an option and reports the long-term experience with the CoreTherm (CoreTherm Operations AB, Sweden) device.
authors.affiliation: Long Island Jewish Medical Center, 270-05 76th Avenue, New Hyde Park, NY 11040, USA. impevan@optonline.net
authors.forename: Evan R
authors.initials: ER
authors.lastname: Eisenberg
authors.forename: Gopal H
authors.initials: GH
authors.lastname: Badlani
mesh_terms: D003972:Diathermy / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D008297:Male; D008872:Microwaves / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000628:therapy*; D020728:Transurethral Resection of Prostate / Q000295:instrumentation / Q000379:methods*; D016896:Treatment Outcome